Assembly Actions -
Lowercase Senate Actions - UPPERCASE |
|
---|---|
Oct 07, 2021 |
signed chap.434 |
Oct 06, 2021 |
delivered to governor |
Jun 07, 2021 |
returned to senate passed assembly ordered to third reading rules cal.405 substituted for a128 |
Jun 07, 2021 |
substituted by s6044 rules report cal.405 reported |
Jun 03, 2021 |
reported referred to rules |
May 24, 2021 |
reported referred to ways and means |
Jan 06, 2021 |
referred to alcoholism and drug abuse |
Assembly Bill A128
Signed By Governor2021-2022 Legislative Session
Sponsored By
ROSENTHAL L
Archive: Last Bill Status Via S6044 - Signed by Governor
- Introduced
-
- In Committee Assembly
- In Committee Senate
-
- On Floor Calendar Assembly
- On Floor Calendar Senate
-
- Passed Assembly
- Passed Senate
- Delivered to Governor
- Signed By Governor
Actions
Votes
co-Sponsors
Albert A. Stirpe
Mike Reilly
2021-A128 (ACTIVE) - Details
2021-A128 (ACTIVE) - Bill Text download pdf
S T A T E O F N E W Y O R K ________________________________________________________________________ 128 2021-2022 Regular Sessions I N A S S E M B L Y (PREFILED) January 6, 2021 ___________ Introduced by M. of A. L. ROSENTHAL, STIRPE, REILLY -- read once and referred to the Committee on Alcoholism and Drug Abuse AN ACT to amend the mental hygiene law, in relation to requiring the office of addiction services and supports to maintain an online direc- tory of distributors of opioid antagonists THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: Section 1. Section 19.09 of the mental hygiene law is amended by adding a new subdivision (l) to read as follows: (L)(1) THE OFFICE, IN CONSULTATION WITH THE DEPARTMENT OF HEALTH, SHALL MAINTAIN ON ITS WEBSITE A PUBLICLY AVAILABLE DIRECTORY OF ALL DISTRIBUTORS OF OPIOID ANTAGONISTS TO THE PUBLIC, INCLUDING BUT NOT LIMITED TO, PHARMACIES, PREVENTION PROGRAMS AND NOT-FOR-PROFITS. AS USED IN THIS SUBDIVISION, THE FOLLOWING TERMS SHALL HAVE THE FOLLOWING MEAN- INGS: (I) "OPIOID" MEANS AN OPIATE AS DEFINED IN SECTION THIRTY-THREE HUNDRED TWO OF THE PUBLIC HEALTH LAW. (II) "OPIOID ANTAGONIST" MEANS A FEDERAL FOOD AND DRUG ADMINISTRA- TION-APPROVED DRUG THAT, WHEN ADMINISTERED, NEGATES OR NEUTRALIZES IN WHOLE OR IN PART THE PHARMACOLOGICAL EFFECTS OF AN OPIOID IN THE BODY. THE OPIOID ANTAGONIST SHALL BE LIMITED TO NALOXONE OR OTHER MEDICATIONS APPROVED BY THE DEPARTMENT OF HEALTH FOR THIS PURPOSE. (2) THE DIRECTORY REQUIRED BY THIS SUBDIVISION SHALL INCLUDE AND BE SEARCHABLE BY THE FOLLOWING INFORMATION: (I) ADDRESSES OF EACH DISTRIBUTOR OF OPIOID ANTAGONISTS; (II) CONTACT INFORMATION, SUCH AS PHONE NUMBERS OR EMAIL ADDRESSES, FOR EACH DISTRIBUTOR; (III) SERVICES OFFERED BY EACH DISTRIBUTOR AT EACH LOCATION IF MORE THAN ONE, AS WELL AS INFORMATION PROVIDING WHICH OPIOID ANTAGONISTS ARE CURRENTLY AVAILABLE AT EACH DISTRIBUTOR; EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
Comments
Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.
Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.
Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.